- Home
- ADPT vs CGAU Comparison
ADPT vs CGAU Comparison
Compare ADPT & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CGAU
- Stock Information
- Founded
- ADPT 2009
- CGAU 2002
- Country
- ADPT United States
- CGAU Canada
- Employees
- ADPT N/A
- CGAU N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CGAU Precious Metals
- Sector
- ADPT Health Care
- CGAU Basic Materials
- Exchange
- ADPT Nasdaq
- CGAU Nasdaq
- Market Cap
- ADPT 2.6B
- CGAU 2.4B
- IPO Year
- ADPT 2019
- CGAU N/A
- Fundamental
- Price
- ADPT $20.36
- CGAU $12.36
- Analyst Decision
- ADPT Strong Buy
- CGAU Buy
- Analyst Count
- ADPT 10
- CGAU 3
- Target Price
- ADPT $16.60
- CGAU $14.17
- AVG Volume (30 Days)
- ADPT 2.4M
- CGAU 1.2M
- Earning Date
- ADPT 11-05-2025
- CGAU 10-28-2025
- Dividend Yield
- ADPT N/A
- CGAU 1.61%
- EPS Growth
- ADPT N/A
- CGAU 236.39
- EPS
- ADPT N/A
- CGAU 1.60
- Revenue
- ADPT $252,754,000.00
- CGAU $1,285,392,000.00
- Revenue This Year
- ADPT $36.43
- CGAU $9.10
- Revenue Next Year
- ADPT $12.31
- CGAU $13.13
- P/E Ratio
- ADPT N/A
- CGAU $7.75
- Revenue Growth
- ADPT 42.57
- CGAU 2.66
- 52 Week Low
- ADPT $4.76
- CGAU $5.41
- 52 Week High
- ADPT $20.76
- CGAU $12.80
- Technical
- Relative Strength Index (RSI)
- ADPT 73.37
- CGAU 59.77
- Support Level
- ADPT $13.28
- CGAU $11.34
- Resistance Level
- ADPT $14.24
- CGAU $12.35
- Average True Range (ATR)
- ADPT 1.19
- CGAU 0.47
- MACD
- ADPT 0.57
- CGAU -0.01
- Stochastic Oscillator
- ADPT 95.19
- CGAU 84.87
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.